Compare OSPN & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OSPN | FLGT |
|---|---|---|
| Founded | 1991 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 500.5M | 579.9M |
| IPO Year | 2000 | 2016 |
| Metric | OSPN | FLGT |
|---|---|---|
| Price | $15.52 | $20.30 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | $16.67 | ★ $28.33 |
| AVG Volume (30 Days) | ★ 373.6K | 269.4K |
| Earning Date | 04-30-2026 | 05-01-2026 |
| Dividend Yield | ★ 4.53% | N/A |
| EPS Growth | ★ 28.77 | N/A |
| EPS | ★ 0.30 | N/A |
| Revenue | ★ $243,180,000.00 | $18,730,000.00 |
| Revenue This Year | $3.22 | $10.09 |
| Revenue Next Year | $3.16 | $12.18 |
| P/E Ratio | $51.88 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.07 | $13.46 |
| 52 Week High | $16.41 | $31.04 |
| Indicator | OSPN | FLGT |
|---|---|---|
| Relative Strength Index (RSI) | 65.40 | 55.36 |
| Support Level | $14.95 | $13.91 |
| Resistance Level | $16.09 | $21.59 |
| Average True Range (ATR) | 0.53 | 0.68 |
| MACD | 0.05 | -0.11 |
| Stochastic Oscillator | 73.87 | 29.84 |
OneSpan Inc is a provider of information technology security solutions for banking and financial services and application security markets. The company build secure, seamless, and trusted digital experiences through two solution portfolios: Cybersecurity solutions engaged in protecting identities, securing mobile apps, and safeguarding access through high-assurance authentication, threat intelligence, fraud prevention, and robust mobile app protection, defending users, devices, and applications against sophisticated attacks, while Digital agreement solutions focuses on streamlining workflows with secure e-signatures, identity verification, and smart digital forms, built to enable speed, compliance and other customer experiences.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.